Page last updated: 2024-08-22

clodronic acid and Pain

clodronic acid has been researched along with Pain in 74 studies

Research

Studies (74)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (8.11)	18.7374
1990's	33 (44.59)	18.2507
2000's	23 (31.08)	29.6817
2010's	11 (14.86)	24.3611
2020's	1 (1.35)	2.80

Authors

Authors	Studies
Cantarini, L; Conticini, E; Falsetti, P; Frediani, B; Giannotti, S; Migliore, A; Nicosia, A; Pierguidi, S; Toscano, C	1
Abdi-Ali, L; Campostrini, L; Carbonare, LD; Povino, MR; Sacco, S; Saviola, G	1
Biotti, A; Bovi, M; Cheri, S; Dalle Carbonare, L; Deiana, M; Mottes, M; Perduca, M; Pisani, A; Valenti, MT	1
Mert, T; Sahin, E; Sahin, M; Yaman, S	1
Godai, K; Hasegawa-Moriyama, M; Kanmura, Y; Kojima, M; Kurimoto, T; Kuwaki, T; Nakama, M	1
Endo, Y; Nemoto, W; Shima, K; Sugawara, S; Takano-Yamamoto, T; Tan-No, K; Tsuchiya, M	1
Calcagnile, F; Muratore, M; Quarta, E; Quarta, L	1
Abdi-Ali, L; Baiardi, P; Benucci, M; Saviola, G	1
Abdi-Ali, L; Baiardi, P; Benucci, M; Campostrini, L; Manfredi, M; Mannoni, A; Sacco, S; Saviola, G	1
Endo, Y; Kim, S; Kuroishi, T; Okada, S; Seiryu, M; Sugawara, S; Takano-Yamamoto, T	1
Gunay, I; Guzel, AI; Mert, T; Ocal, I	1
Iannitti, T; Palmieri, B; Rottigni, V	1
Monteforte, P; Rovetta, G	1
Bowes, M; Chan, O; Fox, AJ; Glatt, M; Green, J; Kesingland, A; Kidd, BL; McNair, K; Medhurst, SJ; Patel, S; Urban, LA; Walker, K	1
Cook, R; Major, PP	1
Chi, K; Ding, K; Elliott, C; Ernst, DS; Moore, MJ; Parulekar, W; Reyno, L; Tannock, IF; Venner, PM; Winquist, EW	1
Dearnaley, DP; Mason, MD; Moffat, LE; Naylor, SL; Parmar, MK; Powell, CS; Robinson, AC; Stott, M; Sydes, MR; Thompson, PM	1
Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R	1
Campagnari, JC; Hering, F; Rodrigues, P	1
Clemons, MJ; Cole, DE; Dranitsaris, G; Ooi, WS; Pritchard, KI; Sukovic, T; Trudeau, M; Verma, S; Wong, BY; Yogendran, G	1
Beard, DJ; Douglas, DL; Duckworth, T; Kanis, JA; Preston, C; Russell, RG; Smith, TW; Underwood, I; Woodhead, JS	1
Vorreuther, R	1
Cresswell, SM; English, PJ; Hall, RR; Marsh, MM; Roberts, JT	1
Ralston, SH; Reed, NS; Robertson, AG	1
Elomaa, I; Kylmälä, T; Risteli, J; Risteli, L; Tammela, T; Taube, T	1
Kanis, JA	2
Ashley, S; Hanson, J; Kanis, JA; McCloskey, E; Paterson, AH; Powles, TJ	1
Bauduer, F; Delmer, A	1
Castrén-Kortekangas, P; Kylmälä, T; Seppänen, J; Tammela, TL; Ylitalo, P	1
Body, JJ; Coleman, RE; Piccart, M	1
Strang, P	1
Paterson, AH	1
Elomaa, I; Kylmälä, T; Risteli, J; Risteli, L; Tammela, TL; Taube, T	1
Lipton, A	1
Berenson, JR	1
Adami, S	1
Heidenreich, A	1
Chapman, C; Drayson, MT; Dunn, J; Kanis, JA; MacLennan, IC; McCloskey, EV	1
Bloomfield, DJ	1
Kylmälä, T	1
Grotz, W; Niessen, A; Rump, JA; Schmidt-Gayk, H; Schollmeyer, P	1
Bartl, R; Body, JJ; Burckhardt, P; Delmas, PD; Diel, IJ; Fleisch, H; Kanis, JA; Kyle, RA; Mundy, GR; Paterson, AH; Rubens, RD	1
Casciari, C; Cristallini, S; Filipponi, P; Gregorio, F; Policani, G	1
Adami, S; Braga, V; Gatti, D; Gerardi, D; Rossini, M; Zamberlan, N	1
Berthaud, P; Jadaud, E; Lortholary, A	1
Açikgöz, N; Akbulut, H; Arican, A; Cakir, M; Demirkazik, A; Içli, F; Samur, M; Sencan, O	1
Balestra, V; Monteforte, P; Rovetta, G	1
Brion, N; Clerc, D; Paule, B	1
Kanis, JA; McCloskey, EV	1
Cundy, T; Zacharin, M	1
Engelmann, UH; Heidenreich, A; Hofmann, R	1
Brignone, A; Grillo, G; Molfetta, L; Monteforte, P; Rovetta, G	1
Bonabello, A; Bruzzese, T; Galmozzi, MR; Zara, GP	1
Johnson, IS	1
Maggiani, G; Molfetta, L; Monteforte, P; Rovetta, G	1
Assadourian, S; Barbet, N; Bessa, E; Beuzeboc, P; Frenay, M; Mauriac, L; Misset, JL; Monnier, A; Pion, JM; Switsers, O; Tubiana-Hulin, M	1
Molfetta, L; Monteforte, P; Rovetta, G	1
Coleman, RE; Heatley, S; Herling, C; Jagdev, SP; Purohit, P	1
Hamdy, NA; Pelger, RC; Soerdjbalie-Maikoe, V	1
Bastert, G; Diel, IJ; Solomayer, EF	1
Wiffen, PJ; Wong, R	1
Elomaa, I; Laakso, M; Lahtinen, R; Palva, I; Virkkunen, P	1
Ala-Opas, M; Elomaa, I; Jauhiainen, K; Kylmälä, T; Ottelin, J; Roos, L; Ruutu, M; Seppänen, J; Tammela, T; Viitanen, J	1
Benvenuti, F; Colombi, L; Gemelli, MT; Ludovici, M; Neri, B; Pacini, P; Sambataro, S	1
Brasher, P; Bruera, E; Ernst, DS; Jensen, J; MacDonald, RN; Paterson, AH	1
Ashley, S; Ernst, DS; Kanis, JA; McCloskey, EV; Paterson, AH; Powles, TJ	1
Biermann, WA; Cantor, RI; Fellin, FM; Hopkins, L; Jakobowski, J; Newbold, RC	1
Adami, S; Mian, M	1
Ascari, E; Attardo-Parrinello, G; Merlini, G	1
Adami, S; Bianchi, G; Dorizzi, R; Guarrera, G; Lo Cascio, V; Mobilio, G; Rosini, S; Salvagno, G	1
Ascari, E; Attardo-Parrinello, G; Crema, F; Fiorentini, ML; Merlini, G; Pavesi, F	1
Canfield, RE; Jacobs, TP; Siris, ES	1

Reviews

19 review(s) available for clodronic acid and Pain

Article	Year
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. American journal of clinical oncology, 2002, Volume: 25, Issue:6 Suppl 1 Topics: Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Models, Statistical; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid	2002
Bone and cancer: pathophysiology and treatment of metastases. Bone, 1995, Volume: 17, Issue:2 Suppl Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Pain; Pamidronate; Parathyroid Hormone	1995
[Multiple myeloma and bone manifestations. Role of clodronate]. Bulletin du cancer, 1996, Volume: 83, Issue:7 Topics: Analgesics, Non-Narcotic; Bone Density; Bone Diseases; Clodronic Acid; Humans; Hypercalcemia; Magnetic Resonance Imaging; Multiple Myeloma; Osteolysis; Pain; Quality of Life; Radiography; Treatment Outcome	1996
Use of bisphosphonates in cancer patients. Cancer treatment reviews, 1996, Volume: 22, Issue:4 Topics: Alendronate; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Pain; Pamidronate; Structure-Activity Relationship	1996
Analgesic effect of bisphosphonates on bone pain in breast cancer patients: a review article. Acta oncologica (Stockholm, Sweden), 1996, Volume: 35 Suppl 5 Topics: Analgesia; Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Osteoclasts; Pain; Pamidronate	1996
Rationale for the use of bisphosphonates in breast cancer. Acta oncologica (Stockholm, Sweden), 1996, Volume: 35 Suppl 5 Topics: Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Clodronic Acid; Cost-Benefit Analysis; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Osteoclasts; Pain; Pamidronate; Quality of Life	1996
Should bisphosphonates be standard therapy for bone pain? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:3 Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Male; Pain	1997
Bisphosphonates and breast carcinoma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Bone Diseases; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcification, Physiologic; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Pain; Pamidronate; Treatment Outcome	1997
Bisphosphonates in multiple myeloma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Bone Diseases; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Multiple Myeloma; Pain; Pamidronate; Randomized Controlled Trials as Topic	1997
Bisphosphonates in prostate carcinoma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Alendronate; Biomarkers; Bone Diseases; Bone Neoplasms; Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Male; Neoplasm Invasiveness; Osteoclasts; Pain; Prostatic Neoplasms	1997
Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:3 Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Evidence-Based Medicine; Female; Humans; Male; Multiple Myeloma; Pain; Pamidronate; Practice Guidelines as Topic; Prostatic Neoplasms; Randomized Controlled Trials as Topic	1998
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:12 Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Multiple Myeloma; Pain; Pamidronate	1998
[Bisphosphonates and bone metastases]. Bulletin du cancer, 1999, Volume: 86, Issue:9 Topics: Antineoplastic Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Male; Multiple Myeloma; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic	1999
Bisphosphonates in multiple myeloma. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Suppl Topics: Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Multiple Myeloma; Pain; Pamidronate	2000
Strategies for management of prostate cancer-related bone pain. Drugs & aging, 2001, Volume: 18, Issue:12 Topics: Analgesics; Animals; Bone Neoplasms; Clodronic Acid; Humans; Male; Pain; Pain Management; Prostatic Neoplasms; Radioisotopes	2001
Treatment of metastatic bone disease in breast cancer: bisphosphonates. Clinical breast cancer, 2000, Volume: 1, Issue:1 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Pain; Pamidronate; Patient Selection; Survival Analysis; Treatment Outcome	2000
Bisphosphonates for the relief of pain secondary to bone metastases. The Cochrane database of systematic reviews, 2002, Issue:2 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Pain; Pamidronate; Randomized Controlled Trials as Topic	2002
Treatment of skeletal disease in breast cancer with clodronate. Bone, 1991, Volume: 12 Suppl 1 Topics: Administration, Oral; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Injections, Intravenous; Osteolysis; Pain; Palliative Care; Prospective Studies; Spinal Fractures; Treatment Outcome	1991
An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone. Bone, 1991, Volume: 12 Suppl 1 Topics: Ambulatory Care; Analgesics; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Cost-Benefit Analysis; Costs and Cost Analysis; Epidural Space; Fractures, Spontaneous; Hospitalization; Hospitals, University; Humans; Hypercalcemia; Incidence; Length of Stay; Osteolysis; Outpatient Clinics, Hospital; Pain; Palliative Care; Philadelphia; Radiotherapy; Retrospective Studies; Spinal Neoplasms	1991

Trials

34 trial(s) available for clodronic acid and Pain

Article	Year
Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study. Drugs in R&D, 2020, Volume: 20, Issue:1 Topics: Aged; Bone Density Conservation Agents; Clodronic Acid; Dose-Response Relationship, Drug; Female; Humans; Male; Osteoarthritis, Knee; Pain; Pain Measurement; Time Factors; Treatment Outcome	2020
Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation). Clinical rheumatology, 2017, Volume: 36, Issue:10 Topics: Aged; Analgesics; Anti-Inflammatory Agents; Antirheumatic Agents; Bone Density Conservation Agents; Cartilage Oligomeric Matrix Protein; Clodronic Acid; Diphosphonates; Female; Hand Joints; Humans; Injections, Intramuscular; Male; Middle Aged; Osteoarthritis; Pain; Pilot Projects; Single-Blind Method; Treatment Outcome	2017
"Twice-a-month" clodronate 200 mg IM: a new dosing regimen and improved therapy adherence in the treatment of postmenopausal osteoporosis. Advances in therapy, 2010, Volume: 27, Issue:5 Topics: Aged; Bone Density; Bone Density Conservation Agents; Bone Resorption; Clodronic Acid; Drug Administration Schedule; Female; Femur; Humans; Lumbar Vertebrae; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Pain	2010
Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study. Modern rheumatology, 2012, Volume: 22, Issue:2 Topics: Aged; Antirheumatic Agents; Bone Density Conservation Agents; Clodronic Acid; Female; Hand Joints; Hand Strength; Health Status; Humans; Hydroxychloroquine; Hyperalgesia; Male; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Pilot Projects; Treatment Failure; Treatment Outcome	2012
Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug design, development and therapy, 2013, Volume: 7 Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Clodronic Acid; Cross-Linking Reagents; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Treatment Outcome	2013
Changes in size of periarthritis calcifications in patients with painful shoulder treated with injectable disodium-clodronate. International journal of clinical pharmacology research, 2002, Volume: 22, Issue:1 Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Calcinosis; Clodronic Acid; Female; Humans; Male; Middle Aged; Pain; Periarthritis; Shoulder Joint; Sulfonamides; Syndrome; Tendons; Tissue Adhesions; Treatment Outcome; Ultrasonography	2002
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clodronic Acid; Disease Progression; Double-Blind Method; Humans; Male; Middle Aged; Mitoxantrone; Pain; Pain Measurement; Palliative Care; Prednisone; Prostatic Neoplasms; Quality of Life; Regression Analysis; Statistics, Nonparametric; Survival Analysis; Treatment Outcome	2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). Journal of the National Cancer Institute, 2003, Sep-03, Volume: 95, Issue:17 Topics: Administration, Oral; Aged; Analgesics, Non-Narcotic; Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Neoplasms; Clodronic Acid; Digestive System; Diphosphonates; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Imidazoles; Male; Middle Aged; Odds Ratio; Pain; Prostatic Neoplasms; Research Design; Survival Analysis; Treatment Outcome; United Kingdom; Zoledronic Acid	2003
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-20, Volume: 24, Issue:30 Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Disease Progression; Drug Resistance; Female; Humans; Imidazoles; Middle Aged; Pain; Palliative Care; Pamidronate; Prospective Studies; Treatment Outcome; Zoledronic Acid	2006
Biphosphonates as an adjunct to palliative therapy of bone metastases from prostatic carcinoma. A pilot study on clodronate. British journal of urology, 1993, Volume: 72, Issue:5 Pt 2 Topics: Aged; Bone Neoplasms; Clodronic Acid; Humans; Male; Pain; Palliative Care; Pilot Projects; Prognosis; Prospective Studies; Prostatic Neoplasms; Survival Rate	1993
Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9 Topics: Administration, Oral; Aged; Analgesics; Bone Neoplasms; Clodronic Acid; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pain Measurement	1995
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Neoplasms; Bone Resorption; Clodronic Acid; Collagen; Estramustine; Humans; Male; Middle Aged; Pain; Palliative Care; Peptide Fragments; Procollagen; Prostatic Neoplasms	1993
Effect of concomitant administration of clodronate and estramustine phosphate on their bioavailability in patients with metastasized prostate cancer. Pharmacology & toxicology, 1996, Volume: 79, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analysis of Variance; Antineoplastic Agents, Hormonal; Biological Availability; Bone Neoplasms; Carcinoma; Clodronic Acid; Drug Synergism; Drug Therapy, Combination; Estramustine; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Pain; Prostatic Neoplasms	1996
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer. British journal of cancer, 1997, Volume: 76, Issue:7 Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Collagen; Double-Blind Method; Humans; Injections, Intravenous; Male; Middle Aged; Pain; Peptide Fragments; Procollagen; Prospective Studies; Prostatic Neoplasms	1997
Bisphosphonates in multiple myeloma. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Bone Diseases; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Multiple Myeloma; Pain; Pamidronate; Randomized Controlled Trials as Topic	1997
[Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate]. Der Urologe. Ausg. A, 1997, Volume: 36, Issue:6 Topics: Analgesics, Non-Narcotic; Antibiotics, Antineoplastic; Bone Neoplasms; Clodronic Acid; Drug Resistance, Neoplasm; Epirubicin; Humans; Male; Pain; Prospective Studies; Prostatic Neoplasms	1997
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. British journal of haematology, 1998, Volume: 100, Issue:2 Topics: Aged; Analgesics, Non-Narcotic; Bone Diseases; Calcium; Clodronic Acid; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Hypocalcemia; Male; Middle Aged; Multiple Myeloma; Pain; Treatment Outcome	1998
Treatment of bone pain after kidney transplantation. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitonin; Calcium; Clodronic Acid; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Pain; Pain Measurement; Postoperative Complications	1998
Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate. Bone, 1998, Volume: 23, Issue:6 Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Resistance; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Peptides; Recurrence; Treatment Outcome	1998
Intramuscular clodronate therapy in postmenopausal osteoporosis. Bone, 1999, Volume: 24, Issue:2 Topics: Aged; Bone Density; Clodronic Acid; Female; Humans; Injections, Intramuscular; Middle Aged; Osteoporosis, Postmenopausal; Pain; Patient Compliance; Time Factors	1999
The effect of two different doses of oral clodronate on pain in patients with bone metastases. Medical oncology (Northwood, London, England), 1999, Volume: 16, Issue:3 Topics: Administration, Oral; Adult; Aged; Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Female; Humans; Male; Middle Aged; Pain; Palliative Care	1999
The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. The Journal of urology, 2001, Volume: 165, Issue:1 Topics: Aged; Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Humans; Karnofsky Performance Status; Male; Pain; Pain Measurement; Palliative Care; Prospective Studies; Prostatic Neoplasms; Time Factors	2001
Disodium clodronate in painful nonresponsive periarthropathy of the hip. International journal of tissue reactions, 2000, Volume: 22, Issue:4 Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Bone Resorption; Bursitis; Clodronic Acid; Drug Therapy, Combination; Female; Femur; Hip Joint; Humans; Male; Pain; Pain Measurement; Tendinopathy	2000
[Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases]. Bulletin du cancer, 2001, Volume: 88, Issue:7 Topics: Administration, Oral; Adult; Aged; Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Double-Blind Method; Female; Hormones; Humans; Middle Aged; Pain; Pain Measurement	2001
[Parenteral disodium-clodronate in patients with rheumatoid arthritis. A two-month open clinical study]. Minerva medica, 2001, Volume: 92, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Arthritis, Rheumatoid; Clodronic Acid; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pain; Time Factors	2001
Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Administration, Oral; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Bone Neoplasms; Bone Resorption; Clodronic Acid; Collagen; Diphosphonates; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pain; Pamidronate	2001
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group. Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Calcium; Clodronic Acid; Double-Blind Method; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Pain; Placebos	1992
Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer. International urology and nephrology, 1992, Volume: 24, Issue:2 Topics: Administration, Oral; Aged; Analgesics; Bone Neoplasms; Calcium; Clodronic Acid; Estramustine; Humans; Male; Pain; Prostatic Neoplasms	1992
Subjective and metabolic effects of clodronate in patients with advanced breast cancer and symptomatic bone metastases. Anti-cancer drugs, 1992, Volume: 3, Issue:2 Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Clodronic Acid; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Middle Aged; Osteocalcin; Pain; Pilot Projects	1992
A double-blind, crossover trial of intravenous clodronate in metastatic bone pain. Journal of pain and symptom management, 1992, Volume: 7, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Clodronic Acid; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pain; Pain Measurement	1992
Treatment of skeletal disease in breast cancer with clodronate. Bone, 1991, Volume: 12 Suppl 1 Topics: Administration, Oral; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Combined Modality Therapy; Double-Blind Method; Fractures, Spontaneous; Humans; Hypercalcemia; Incidence; Injections, Intravenous; Osteolysis; Pain; Palliative Care; Prospective Studies; Spinal Fractures; Treatment Outcome	1991
Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 116 Topics: Administration, Oral; Bone Neoplasms; Clodronic Acid; Diphosphonates; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Multicenter Studies as Topic; Pain; Prostatic Neoplasms; Random Allocation	1989
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate. Archives of internal medicine, 1987, Volume: 147, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Pain	1987
Dichloromethylene diphosphonate action in hematologic and other malignancies. Bone, 1987, Volume: 8 Suppl 1 Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Leukemia, Lymphoid; Male; Multiple Myeloma; Neoplasms; Pain	1987

Other Studies

23 other study(ies) available for clodronic acid and Pain

Article	Year
Clodronate as a Therapeutic Strategy against Osteoarthritis. International journal of molecular sciences, 2017, Dec-13, Volume: 18, Issue:12 Topics: Aged; Biomarkers; Cell Differentiation; Cells, Cultured; Chondrocytes; Chondrogenesis; Clodronic Acid; Collagen Type II; Cytokines; Female; Humans; Middle Aged; Nanoparticles; Osteoarthritis; Pain; Severity of Illness Index; SOX9 Transcription Factor; Stem Cells; Up-Regulation	2017
Anti-inflammatory properties of Liposome-encapsulated clodronate or Anti-Ly6G can be modulated by peripheral or central inflammatory markers in carrageenan-induced inflammation model. Inflammopharmacology, 2019, Volume: 27, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Carrageenan; Clodronic Acid; Disease Models, Animal; Edema; Hyperalgesia; Inflammation; Liposomes; Macrophages; Male; Neutrophils; Pain; Rats; Rats, Wistar; Spinal Cord	2019
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophages. Pain, 2013, Volume: 154, Issue:8 Topics: Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Freund's Adjuvant; Gene Expression Regulation; Heme Oxygenase-1; Hyperalgesia; Inflammation; Lectins, C-Type; Macrophages, Peritoneal; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pain; Pain Measurement; Pain Threshold; Receptors, Cell Surface; Rosiglitazone; Thiazolidinediones; Time Factors	2013
The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways. Biological & pharmaceutical bulletin, 2016, Volume: 39, Issue:5 Topics: Acetic Acid; Adenosine Triphosphate; Analgesics; Animals; Bone Density Conservation Agents; Capsaicin; Clodronic Acid; Etidronic Acid; Excitatory Amino Acid Agonists; Foscarnet; Glutamic Acid; Lumbar Vertebrae; Mice; Mice, Inbred BALB C; N-Methylaspartate; Pain; Sodium-Phosphate Cotransporter Proteins; Spinal Cord; Substance P	2016
Can clodronate be effective in the treatment of disabling hydroxyapatite crystal-deposition disease? A report of two cases. Rheumatology international, 2011, Volume: 31, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Bone Density Conservation Agents; Clodronic Acid; Drug Therapy, Combination; Female; Humans; Hydroxyapatites; Injections, Intramuscular; Methylprednisolone; Pain; Periarthritis; Treatment Outcome	2011
Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone. European journal of pharmacology, 2013, Jan-15, Volume: 699, Issue:1-3 Topics: Acetic Acid; Analgesics; Animals; Capsaicin; Clodronic Acid; Corticosterone; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Etidronic Acid; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Pain; Proto-Oncogene Proteins c-fos	2013
Clodronate changes neurobiological effects of pulsed magnetic field on diabetic rats with peripheral neuropathy. Electromagnetic biology and medicine, 2013, Volume: 32, Issue:3 Topics: Animals; Blood Glucose; Body Size; Clodronic Acid; Diabetic Neuropathies; Hyperalgesia; Insulin; Liposomes; Macrophages; Magnetic Field Therapy; Male; Neurobiology; Pain; Rats; Rats, Wistar	2013
Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain, 2002, Volume: 100, Issue:3 Topics: Animals; Bone Density; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Hyperalgesia; Hyperesthesia; Imidazoles; Models, Animal; Neoplasm Transplantation; Observer Variation; Pain; Pain Measurement; Pain Threshold; Pamidronate; Radiography; Rats; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tibia; Touch; Treatment Outcome; Zoledronic Acid	2002
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. Calcified tissue international, 2004, Volume: 75, Issue:3 Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Tolerance; Etidronic Acid; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Parathyroid Hormone; Risedronic Acid; Treatment Outcome	2004
Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients. Prostate cancer and prostatic diseases, 2004, Volume: 7, Issue:4 Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prospective Studies; Prostatic Neoplasms; Time Factors	2004
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone. Arthritis and rheumatism, 1980, Volume: 23, Issue:10 Topics: Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Humans; Hydroxyproline; Movement; Osteitis Deformans; Pain; Parathyroid Hormone; Phosphates	1980
Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer. British journal of urology, 1995, Volume: 76, Issue:3 Topics: Administration, Oral; Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Drug Resistance; Humans; Infusions, Intravenous; Male; Pain; Pain Measurement; Palliative Care; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Treatment Outcome	1995
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer. The Canadian journal of oncology, 1995, Volume: 5 Suppl 1 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Multiple Myeloma; Osteoporosis; Pain; Pamidronate	1995
Prostate cancer and bone metastases. The effect of clodronate. Annales chirurgiae et gynaecologiae, 1998, Volume: 87, Issue:1 Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Development; Bone Neoplasms; Bone Resorption; Clodronic Acid; Humans; Male; Middle Aged; Pain; Prostatic Neoplasms	1998
No value of oral clodronic acid in malignant osteolysis. Prescrire international, 1998, Volume: 7, Issue:36 Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Clinical Trials as Topic; Clodronic Acid; Double-Blind Method; Drug Evaluation; Humans; Pain; Palliative Care; Treatment Outcome	1998
Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs under experimental and clinical research, 2000, Volume: 26, Issue:1 Topics: Acute Disease; Aged; Analgesics, Non-Narcotic; Clodronic Acid; Female; Humans; Male; Middle Aged; Osteoporosis; Pain; Spinal Fractures	2000
[Biosphonates in oncology]. Presse medicale (Paris, France : 1983), 2000, Apr-08, Volume: 29, Issue:13 Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Neoplasms; Osteolysis; Pain; Pamidronate; Spinal Cord Compression	2000
Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates. The Journal of pediatrics, 2000, Volume: 137, Issue:3 Topics: Analgesics, Non-Narcotic; Bone Density; Child; Clodronic Acid; Diphosphonates; Female; Fractures, Bone; Growth; Humans; Infusions, Intravenous; Male; Osteoporosis; Pain; Pamidronate; Spine; Syndrome; Vision Disorders	2000
Analgesic effect of bisphosphonates in mice. Pain, 2001, Volume: 91, Issue:3 Topics: Abdomen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Gastrointestinal Motility; Male; Mice; Mice, Inbred Strains; Pain; Pain Measurement; Pamidronate; Tail	2001
Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UK. Palliative medicine, 2001, Volume: 15, Issue:2 Topics: Bone Neoplasms; Clodronic Acid; Diphosphonates; Drug Costs; Humans; Pain; Palliative Care; Pamidronate; Practice Patterns, Physicians'; Surveys and Questionnaires; United Kingdom	2001
One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs under experimental and clinical research, 2001, Volume: 27, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Clodronic Acid; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Osteoporosis; Pain; Spinal Fractures	2001
Treatment of painful bone lesions and hypercalcemia. European journal of haematology. Supplementum, 1989, Volume: 51 Topics: Bone Diseases; Clodronic Acid; Diphosphonates; Drug Evaluation; Humans; Hypercalcemia; Multiple Myeloma; Pain; Pilot Projects	1989
Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. The Journal of urology, 1985, Volume: 134, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Bone Resorption; Calcium; Carcinoma; Clodronic Acid; Diphosphonates; Drug Administration Schedule; Humans; Male; Middle Aged; Pain; Prostatic Neoplasms	1985